New insight into intrachromosomal deletions induced by chrysotile in the gpt delta transgenic mutation assay

Environmental Health Perspectives

Volumn 115, Issue 1, 2007, Pages 87-92

  Xu, An ^a,b   Smilenov, Lubomir B ^a   He, Peng ^a   Masumura, Ken Ichi ^c   Nohmi, Takehiko ^c   Yu, Zengliang ^b   Hei, Tom K ^a,d  

^a Columbia University ^*  (United States)

^b INSTITUTE OF PLASMA PHYSICS   (China)

^c NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^d NONE   (United States)

Author keywords

H2AX.; Chrysotile asbestos; Gpt delta transgenic mutation system; Kilobase sized mutation; Oxyradicals

Indexed keywords

ALANINE AMINOTRANSFERASE; ASBESTOS; CATALASE; CHRYSOTILE; DELTA HISTONE H2AX; DOUBLE STRANDED RNA; GENOMIC DNA; HISTONE H2AX; HYDROGEN PEROXIDE; OXYRADICAL; RADICAL; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CHROMOSOME DELETION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA STRAND BREAKAGE; EMBRYO CELL; FIBROBLAST; GENE LOCUS; GENE MUTATION; IN VIVO STUDY; MOUSE; MUTAGENESIS; MUTAGENICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SPECTROSCOPY; TRANSGENIC MOUSE;

ANIMALS; ASBESTOS, SERPENTINE; CELL SURVIVAL; CELLS, CULTURED; CHROMOSOME DELETION; ESCHERICHIA COLI PROTEINS; FIBROBLASTS; HISTONES; MICE; MICE, TRANSGENIC; MUTAGENICITY TESTS; PENTOSYLTRANSFERASES;

MUS MUSCULUS;

EID: 33845974089     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.9425     Document Type: Article

References (42)

1. Bernstein DM, Rogers R, Smith P. 2003. The biopersistence of Canadian chrysotile asbestos following inhalation. Inhal Toxicol 15(13):1247-1274.
2. Coin PG, Roggli VL, Brody AR. 1994. Persistence of long, thin chrysotile asbestos fibers in the lungs of rats. Environ Health Perspect 102(suppl 5):197-199.
3. Dean SW, Brooks TM, Burlinson B, Mirsalis J, Myhr B, Recio L et al. 1999. Transgenic mouse mutation assay systems can play an important role in regulatory mutagenicity testing in vivo for the detection of site-of-contact mutagens. Mutagenesis 14(1):141-151.
4. Fach E, Kristovich R, Long JF, Waldman WJ, Dutta PK, Williams MV. 2003. The effect of iron on the biological activities of erionite and mordenite. Environ Int 29(4):451-458.
5. Gardner MJ, Saracci R. 1989. Effects on health of non-occupational exposure to airborne mineral fibres. IARC Sci Publ 90:375-397.
6. Gustavsson P, Jakobsson R, Johansson H, Lewin F, Norell S, Rutkvist LE. 1998. Occupational exposures and squamous cell carcinoma of the oral cavity, pharynx, larynx, and oesophagus: a case-control study in Sweden. Occup Environ Med 55(6):393-400.
7. Hei TK, Piao CQ, He ZY, Vannais D, Waldren CA. 1992. Chrysotile fiber is a strong mutagen in mammalian cells. Cancer Res 52(22):6305-6309.
8. Hogan B, Beddington R, Constantini F, and Lacy E. 1994. Manipulating the Mouse Embryo, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
9. Horiguchi M, Masumura KI, Ikehata H, Ono T, Kanke Y, Nohmi T. 2001. Molecular nature of ultraviolet B light-induced deletions in the murine epidermis. Cancer Res 61(10):3913-3918.
10. International Agency for Research on Cancer. 1987. Overall Evaluation of Carcinogenicity: an Updating of IARC Monographs Volumes 1-42. IARC Monogr Eval Carcinog Risks Hum Supplement 7.
11. Jaurand MC. 1996. Use of in vitro genotoxicity and cell transformation assays to evaluate the potential carcinogenicity of fibres. IARC Sci Publ 140:55-72.
12. Khanna KK, Jackson SP. 2001. DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet 27(3): 247-254.
13. Kjaerheim K, Ulvestad B, Martinsen JI, Andersen A. 2005. Cancer of the gastrointestinal tract and exposure to asbestos in drinking water among lighthouse keepers (Norway). Cancer Causes Control 16(5):593-598.
14. Kurose A, Tanaka T, Huang X, Halicka HD, Traganos F, Dai W et al. 2005. Assessment of ATM phosphorylation on Ser-1981 induced by DNA topoisomerase I and II inhibitors in relation to Ser-139-histone H2AX phosphorylation, cell cycle phase, and apoptosis. Cytometry A 68(1):1-9.
15. Lezon-Geyda K, Jaime CM, Godbold JH, Savransky EF, Hope A, Kheiri SA, et al. 1996. Chrysotile asbestos fibers mediate homologous recombination in Rat2 lambda fibroblasts: implications for carcinogenesis. Mutat Res 361(2-3):113-120.
16. 2. Blood 95(9):2960-2966.
17. Lowndes NF, Toh GW. 2005. DNA repair: the importance of phosphorylating histone H2AX. Curr Biol 15(3):R99-R102.
18. Masumura K, Totsuka Y, Wakabayashi K, Nohmi T. 2003. Potent genotoxicity of aminophenylnorharman, formed from non-mutagenic norharman and aniline, in the liver of gptdelta transgenic mouse. Carcinogenesis 24(12):1985-1993.
19. Miller A. 2005. Mesothelioma in household members of asbestos-exposed workers: 32 United States cases since 1990. Am J Ind Med 47(5):458-462.
20. 2 induction of gene amplification in hamster cells deficient in DNA double strand break repair. DNA Repair (Amst) 1(6):483-493.
21. - and 6-thioguanine selections. Environ Mol Mutagen 28(4):465-470.
22. Nohmi T, Masumura K. 2005. Molecular nature of intrachromosomal deletions and base substitutions induced by environmental mutagens. Environ Mol Mutagen 45(2-3):150-161.
23. Nohmi T, Masumura KI. 2004. Gpt delta transgenic mouse: a novel approach for molecular dissection of deletion mutations in vivo. Adv Biophys 38:97-121.
24. O'Driscoll M, Jeggo PA. 2006. The role of double-strand break repair - insights from human genetics. Nat Rev Genet 7(1): 45-54.
25. Okayasu R, Takahashi S, Yamada S, Hei TK, Ullrich RL. 1999. Asbestos and DNA double strand breaks. Cancer Res 59(2): 298-300.
26. Pan XL, Day HW, Wang W, Beckett LA, Schenker MB. 2005. Residential proximity to naturally occurring asbestos and mesothelioma risk in California. Am J Respir Crit Care Med 172:1019-1025.
27. + Chinese hamster V79 cells. Cancer Res 58(6):1144-1148.
28. Poser I, Rahman Q, Lohani M, Yadav S, Becker HH, Weiss DG et al. 2004. Modulation of genotoxic effects in asbestos-exposed primary human mesothelial cells by radical scavengers, metal chelators and a glutathione precursor. Mutat Res 559(1-2): 19-27.
29. Radford IR. 2004. Chromosomal rearrangement as the basis for human tumourigenesis. Int J Radiat Biol 80(8):543-557.
30. Rihn B, Coulais C, Kauffer E, Bottin MC, Martin P, Yvon F, et al. 2000. Inhaled crocidolite mutagenicity in lung DNA. Environ Health Perspect 108:341-346.
31. Rom WN, Hammar SP, Rusch V, Dodson R, Hoffman S. 2001. Malignant mesothelioma from neighborhood exposure to anthophyllite asbestos. Am J Ind Med 40(2):211-214.
32. 2 release from human granulocytes during phagocytosis. I. Documentation, quantitation, and some regulating factors. J Clin Invest 55(5): 945-955.
33. Scudiero DA, Shoemaker RH, Paull KD, Monks A, Tierney S, Nofzinger TH, et al. 1988. Evaluation of soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 48:4827-4833.
34. Shibata A, Kamada N, Masumura K, Nohmi T, Kobayashi S, Teraoka H, et al. 2005. Parp-1 deficiency causes an increase of deletion mutations and insertions/rearrangements in vivo after treatment with an alkylating agent. Oncogene 24(8): 1328-1337.
35. Shukla A, Gulumian M, Hei TK, Kamp D, Rahman Q, Mossman BT. 2003. Multiple roles of oxidants in the pathogenesis of asbestos-induced diseases. Free Radic Biol Med 34(9): 1117-1129.
36. 1 mice. Environ Mol Mutagen 26(1):9-15.
37. Timbrell V. 1970. Characteristics of the International Union Against Cancer Standard Reference Samples of Asbestos. In: Pneumoconiosis, Proceedings of the International Conference, April 1969, Johannesburg, South Africa (Shapiro HA, ed). Cape Town, South Africa:Oxford University Press, 28-36.
38. Topinka J, Loli P, Georgiadis P, Dusinska M, Hurbankova M, Kovacikova Z, et al. 2004. Mutagenesis by asbestos in the lung of lambda-lacl transgenic rats. Mutat Res 553(1-2):67-78.
39. Unfried K, Schurkes C, Abel J. 2002. Distinct spectrum of mutations induced by crocidolite asbestos: clue for 8-hydroxydeoxyguanosine-dependent mutagenesis in vivo. Cancer Res 62(1):99-104.
40. Walker VE, Andrews JL, Upton PB, Skopek TR, deBoer JG, Walker DM, et al. 1999. Detection of cyclophosphamide-induced mutations at the Hprt but not the lacl locus in splenic lymphocytes of exposed mice. Environ Mol Mutagen 34(2-3): 167-181.
41. 2. Arch Biochem Biophys 228:373-376.
42. Xu A, Zhou H, Yu DZ, Hei TK. 2002. Mechanisms of the genotoxicity of crocidolite asbestos in mammalian cells: implication from mutation patterns induced by reactive oxygen species. Environ Health Perspect 110:1003-1008.